NEW YORK--(BUSINESS WIRE)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, announced today that Dr. Yaron Werber, Ovid’s Chief Financial Officer, will participate on a panel, titled “Rare Diseases – Behind Enzyme Replacement Therapy,” during Citi’s 10th Annual Biotech Conference, taking place at the Mandarin Oriental New York, September 9-10, 2015. The panel will convene on Thursday, September 10, at 9am Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
